181 related articles for article (PubMed ID: 22306046)
1. Lack of an effect of Lactobacillus reuteri DSM 17938 in preventing nosocomial diarrhea in children: a randomized, double-blind, placebo-controlled trial.
Wanke M; Szajewska H
J Pediatr; 2012 Jul; 161(1):40-3.e1. PubMed ID: 22306046
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of Lactobacillus reuteri DSM 17938 for the Prevention of Nosocomial Diarrhea in Children: A Randomized, Double-blind, Placebo-controlled Trial.
Urbańska M; Gieruszczak-Białek D; Szymański H; Szajewska H
Pediatr Infect Dis J; 2016 Feb; 35(2):142-5. PubMed ID: 26551445
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in infants.
Szajewska H; Kotowska M; Mrukowicz JZ; Armańska M; Mikołajczyk W
J Pediatr; 2001 Mar; 138(3):361-5. PubMed ID: 11241043
[TBL] [Abstract][Full Text] [Related]
4. Diarrhea in preschool children and Lactobacillus reuteri: a randomized controlled trial.
Gutierrez-Castrellon P; Lopez-Velazquez G; Diaz-Garcia L; Jimenez-Gutierrez C; Mancilla-Ramirez J; Estevez-Jimenez J; Parra M
Pediatrics; 2014 Apr; 133(4):e904-9. PubMed ID: 24639271
[TBL] [Abstract][Full Text] [Related]
5. Lactobacillus reuteri DSM 17938 in the prevention of antibiotic-associated diarrhoea in children: a randomized clinical trial.
Kołodziej M; Szajewska H
Clin Microbiol Infect; 2019 Jun; 25(6):699-704. PubMed ID: 30149135
[TBL] [Abstract][Full Text] [Related]
6. Lactobacillus reuteri DSM 17938 in the prevention of antibiotic-associated diarrhoea in children: protocol of a randomised controlled trial.
Kołodziej M; Szajewska H
BMJ Open; 2017 Jan; 7(1):e013928. PubMed ID: 28057659
[TBL] [Abstract][Full Text] [Related]
7. Lactobacillus reuteri DSM 17938 shortens acute infectious diarrhea in a pediatric outpatient setting.
Dinleyici EC; Dalgic N; Guven S; Metin O; Yasa O; Kurugol Z; Turel O; Tanir G; Yazar AS; Arica V; Sancar M; Karbuz A; Eren M; Ozen M; Kara A; Vandenplas Y
J Pediatr (Rio J); 2015; 91(4):392-6. PubMed ID: 25986615
[TBL] [Abstract][Full Text] [Related]
8. A systematic review and meta-analysis: the therapeutic and preventive effect of Lactobacillus reuteri DSM 17,938 addition in children with diarrhea.
Sun X; Kong J; Zhu S; Liu C
BMC Gastroenterol; 2023 May; 23(1):141. PubMed ID: 37147591
[TBL] [Abstract][Full Text] [Related]
9. Randomized trial of probiotics and calcium on diarrhea and respiratory tract infections in Indonesian children.
Agustina R; Kok FJ; van de Rest O; Fahmida U; Firmansyah A; Lukito W; Feskens EJ; van den Heuvel EG; Albers R; Bovee-Oudenhoven IM
Pediatrics; 2012 May; 129(5):e1155-64. PubMed ID: 22492764
[TBL] [Abstract][Full Text] [Related]
10. Randomised clinical trial: Lactobacillus reuteri DSM 17938 vs. placebo in children with acute diarrhoea--a double-blind study.
Francavilla R; Lionetti E; Castellaneta S; Ciruzzi F; Indrio F; Masciale A; Fontana C; La Rosa MM; Cavallo L; Francavilla A
Aliment Pharmacol Ther; 2012 Aug; 36(4):363-9. PubMed ID: 22680836
[TBL] [Abstract][Full Text] [Related]
11. Lack of Efficacy of Lactobacillus reuteri DSM 17938 for the Treatment of Acute Gastroenteritis: A Randomized Controlled Trial.
Szymański H; Szajewska H
Pediatr Infect Dis J; 2019 Oct; 38(10):e237-e242. PubMed ID: 31033909
[TBL] [Abstract][Full Text] [Related]
12. Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis.
Shornikova AV; Casas IA; Mykkänen H; Salo E; Vesikari T
Pediatr Infect Dis J; 1997 Dec; 16(12):1103-7. PubMed ID: 9427453
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind, placebo-controlled pilot study of Lactobacillus reuteri ATCC 55730 for the prevention of antibiotic-associated diarrhea in hospitalized adults.
Cimperman L; Bayless G; Best K; Diligente A; Mordarski B; Oster M; Smith M; Vatakis F; Wiese D; Steiber A; Katz J
J Clin Gastroenterol; 2011 Oct; 45(9):785-9. PubMed ID: 21552138
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of an Oral Rehydration Solution Enriched with
Maragkoudaki M; Chouliaras G; Moutafi A; Thomas A; Orfanakou A; Papadopoulou A
Nutrients; 2018 Sep; 10(9):. PubMed ID: 30200394
[TBL] [Abstract][Full Text] [Related]
15. Lactobacillus reuteri as a therapeutic agent in acute diarrhea in young children.
Shornikova AV; Casas IA; Isolauri E; Mykkänen H; Vesikari T
J Pediatr Gastroenterol Nutr; 1997 Apr; 24(4):399-404. PubMed ID: 9144122
[TBL] [Abstract][Full Text] [Related]
16. Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: a systematic review of published randomized, double-blind, placebo-controlled trials.
Szajewska H; Mrukowicz JZ
J Pediatr Gastroenterol Nutr; 2001 Oct; 33 Suppl 2():S17-25. PubMed ID: 11698781
[TBL] [Abstract][Full Text] [Related]
17. Probiotics for infantile colic: a randomized, double-blind, placebo-controlled trial investigating Lactobacillus reuteri DSM 17938.
Chau K; Lau E; Greenberg S; Jacobson S; Yazdani-Brojeni P; Verma N; Koren G
J Pediatr; 2015 Jan; 166(1):74-8. PubMed ID: 25444531
[TBL] [Abstract][Full Text] [Related]
18. Lactobacillus reuteri DSM 17938 for the management of infantile colic in breastfed infants: a randomized, double-blind, placebo-controlled trial.
Szajewska H; Gyrczuk E; Horvath A
J Pediatr; 2013 Feb; 162(2):257-62. PubMed ID: 22981952
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of the prenatal administration of Lactobacillus reuteri LR92 DSM 26866 on the prevention of infantile colic: a randomized control trial.
Pourmirzaiee MA; Famouri F; Moazeni W; Hassanzadeh A; Hajihashemi M
Eur J Pediatr; 2020 Oct; 179(10):1619-1626. PubMed ID: 32372186
[TBL] [Abstract][Full Text] [Related]
20. Lactobacillus reuteri DSM 17938 in infantile colic: a randomized, double-blind, placebo-controlled trial.
Savino F; Cordisco L; Tarasco V; Palumeri E; Calabrese R; Oggero R; Roos S; Matteuzzi D
Pediatrics; 2010 Sep; 126(3):e526-33. PubMed ID: 20713478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
